BIIB Biogen Inc.
BIIB Biogen Inc.
Healthcare · Drug Manufacturers - General
Desk view
Market read
Scan convergence 3 scans as of 2026-10-23 3 bull converging
POC $174.38 · VWAP $189.15 · +32.5% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 related campaign
BIIB Price Structure
Loading timeframes…
Peers
Every watchlist BIIB belongs to, members best 30-day change first — BIIB highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@healthcare-scan
@healthcare
@ibb
@biotech-scan
Reported the quarter ending 2026-06-30: revenue $2.74B, diluted EPS $0.66, net income $98M (the desk's provider cache). Across the print the stock moved -3.0% (close before → first close after).
full note →Against street estimates
How BIIB's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about BIIB from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled today · Oct 23
- BIIB News Today | Why did Biogen stock go down today? $BIIB
- Biogen Inc. (BIIB) stock price, news, quote and history - Yahoo Finance
- Biogen, Inc
- Biogen: Growth Is Back, But It Came At A Price (NASDAQ:BIIB) | Seeking Alpha
- Biogen (BIIB) Q2 2026 Earnings Call Transcript | The Motley Fool
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
BIIB research tape
151 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.